TP53 and chronic obstructive pulmonary disease: IL-17A, p53, and plasminogen activator inhibitor (PAI)-1 were higher in smokers with COPD than in healthy smokers (HSs) and healthy control subjects (HCs) (Gouda et al., 2018a).